-
1
-
-
77958501111
-
Effects of A2 type botulinum toxin on spontaneous miniature and evoked transmitter release from the rat spinal excitatory and inhibitory synapses
-
N. Akaike, Y. Ito, M.C. Shin, K. Nonaka, Y. Torii, T. Harakawa, A. Ginnaga, S. Kozaki, and R. Kaji Effects of A2 type botulinum toxin on spontaneous miniature and evoked transmitter release from the rat spinal excitatory and inhibitory synapses Toxicon 56 8 2010 1315 1326
-
(2010)
Toxicon
, vol.56
, Issue.8
, pp. 1315-1326
-
-
Akaike, N.1
Ito, Y.2
Shin, M.C.3
Nonaka, K.4
Torii, Y.5
Harakawa, T.6
Ginnaga, A.7
Kozaki, S.8
Kaji, R.9
-
2
-
-
34548307281
-
Comparison of Botulinum Neurotoxin Preparations for the Treatment of Cervical Dystonia
-
DOI 10.1016/j.clinthera.2007.07.020, PII S0149291807002123
-
M.A. Chapman, R. Barron, D.C. Tanis, C.E. Gill, and P.D. Charles Comparison of botulinum neurotoxin preparations for the treatment of cervical dystonia Clin. Ther. 29 7 2007 1325 1337 (Pubitemid 47348118)
-
(2007)
Clinical Therapeutics
, vol.29
, Issue.7
, pp. 1325-1337
-
-
Chapman, M.A.1
Barron, R.2
Tanis, D.C.3
Gill, C.E.4
Charles, P.D.5
-
3
-
-
72849120235
-
®: Long term results
-
®: long term results Eur. J. Neurol. 16 Suppl. 2 2009 2 5
-
(2009)
Eur. J. Neurol.
, vol.16
, Issue.SUPPL. 2
, pp. 2-5
-
-
Dressler, D.1
-
4
-
-
0028131916
-
Serial neurophysiological studies of intramuscular botulinum-A toxin in humans
-
DOI 10.1002/mus.880171207
-
J.A. Hamjian, and F.O. Walker Serial neurophysiological studies of intramuscular botulinum-A toxin in humans Muscle Nerve 17 12 1994 1385 1392 (Pubitemid 24362810)
-
(1994)
Muscle and Nerve
, vol.17
, Issue.12
, pp. 1385-1392
-
-
Hamjian, J.A.1
Walker, F.O.2
-
5
-
-
20944432519
-
Efficacy and tolerability of a botulinum toxin type a free of complexing proteins (NT 201) compared with commercially available botulinum toxin type a (BOTOX®) in healthy volunteers
-
DOI 10.1007/s00702-004-0234-8
-
®) in healthy volunteers J. Neural. Transm. 112 7 2005 905 913 (Pubitemid 40869079)
-
(2005)
Journal of Neural Transmission
, vol.112
, Issue.7
, pp. 905-913
-
-
Jost, W.H.1
Kohl, A.2
Brinkmann, S.3
Comes, G.4
-
6
-
-
0030614321
-
The EDB test - A clinical test for the detection of antibodies to botulinum toxin type A
-
DOI 10.1002/mds.870120116
-
K.R. Kessler, and R. Benecke The EBD test - a clinical test for the detection of antibodies to botulinum toxin type A Mov. Disord. 12 1 1997 95 99 (Pubitemid 27032886)
-
(1997)
Movement Disorders
, vol.12
, Issue.1
, pp. 95-99
-
-
Kessler, K.R.1
Benecke, R.2
-
7
-
-
0021181880
-
Principles and pitfalls of nerve conduction studies
-
J. Kimura Principles and pitfalls of nerve conduction studies Ann. Neurol. 16 4 1984 415 429 (Pubitemid 14021820)
-
(1984)
Annals of Neurology
, vol.16
, Issue.4
, pp. 415-429
-
-
Kimura, J.1
-
9
-
-
0033911430
-
F-wave latency serves as the most reproducible measure in nerve conduction studies of diabetic polyneuropathy: Multicentre analysis in healthy subjects and patients with diabetic polyneuropathy
-
N. Kohara, J. Kimura, R. Kaji, Y. Goto, J. Ishii, M. Takiguchi, and M. Nakai F-wave latency serves as the most reproducible measure in nerve conduction studies of diabetic polyneuropathy: multicenter analysis in healthy subjects and patients with diabetic polyneuropathy Diabetologia 43 7 2000 915 921 (Pubitemid 30463172)
-
(2000)
Diabetologia
, vol.43
, Issue.7
, pp. 915-921
-
-
Kohara, N.1
Kimura, J.2
Kaji, R.3
Goto, Y.4
Ishii, J.5
Takiguchi, M.6
Nakai, M.7
-
10
-
-
74049135356
-
Repeatability of nerve conduction measurements derived entirely by computer methods
-
10.1186/1475-925X-8-33
-
X. Kong, E.A. Lesser, and S.N. Gozani Repeatability of nerve conduction measurements derived entirely by computer methods Biomed. Eng. Online 8 2009 33 10.1186/1475-925X-8-33
-
(2009)
Biomed. Eng. Online
, vol.8
, pp. 33
-
-
Kong, X.1
Lesser, E.A.2
Gozani, S.N.3
-
11
-
-
0028824899
-
Immunological characterization of the neurotoxin produced by Clostridium botulinum type A associated with infant botulism in Japan
-
S. Kozaki, S. Nakaue, and Y. Kamata Immunological characterization of the neurotoxin produced by Clostridium botulinum type A associated with infant botulism in Japan Microbiol. Immunol. 39 10 1995 767 774
-
(1995)
Microbiol. Immunol.
, vol.39
, Issue.10
, pp. 767-774
-
-
Kozaki, S.1
Nakaue, S.2
Kamata, Y.3
-
12
-
-
27744451445
-
Production of anti-neurotoxin antibody is enhanced by two subcomponents, HA1 and HA3b, of Clostridium botulinum type B 16S toxin-haemagglutinin
-
DOI 10.1099/mic.0.28421-0
-
J.C. Lee, K. Yokota, H. Arimitsu, H.J. Hwang, Y. Sakaguchi, J. Cui, K. Takeshi, T. Watanabe, T. Ohyama, and K. Oguma Production of anti-neurotoxin antibody is enhanced by two subcomponents, HA1 and HA3b, of Clostridium botulinum type B 16S toxin-haemagglutinin Microbiology 151 Pt 11 2005 3739 3747 (Pubitemid 41632084)
-
(2005)
Microbiology
, vol.151
, Issue.11
, pp. 3739-3747
-
-
Lee, J.-C.1
Yokota, K.2
Arimitsu, H.3
Hwang, H.-J.4
Sakaguchi, Y.5
Cui, J.6
Takeshi, K.7
Watanabe, T.8
Ohyama, T.9
Oguma, K.10
-
13
-
-
6844239534
-
A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport® and Botox® in the treatment of cervical dystonia
-
® in the treatment of cervical dystonia J. Neurol. Neurosurg. Psychiatr. 64 1 1998 6 12 (Pubitemid 28156530)
-
(1998)
Journal of Neurology Neurosurgery and Psychiatry
, vol.64
, Issue.1
, pp. 6-12
-
-
Odergren, T.1
Hjaltason, H.2
Kaakkola, S.3
Solders, G.4
Hanko, J.5
Fehling, C.6
Marttila, R.J.7
Lundh, H.8
Gedin, S.9
Westergren, I.10
Richardson, A.11
Dott, C.12
Cohen, H.13
-
14
-
-
0028018244
-
Measurement of botulinum toxin activity: Evaluation of the lethality assay
-
DOI 10.1006/taap.1994.1181
-
L.B. Pearce, G.E. Borodic, E.R. First, and R.D. MacCallum Measurement of botulinum toxin activity: evaluation of the lethality assay Toxicol. Appl. Pharmacol. 128 1 1994 69 77 (Pubitemid 24289132)
-
(1994)
Toxicology and Applied Pharmacology
, vol.128
, Issue.1
, pp. 69-77
-
-
Pearce, L.B.1
Borodic, G.E.2
First, E.R.3
MacCallum, R.D.4
-
15
-
-
78650885033
-
Botulinum neurotoxin subtype A2 enters neuronal cells faster than subtype A1
-
C.L. Pier, C. Chen, W.H. Tepp, G. Lin, K.D. Janda, J.T. Barbieri, S. Pellett, and E.A. Johnson Botulinum neurotoxin subtype A2 enters neuronal cells faster than subtype A1 FEBS Lett. 585 1 2011 199 206
-
(2011)
FEBS Lett.
, vol.585
, Issue.1
, pp. 199-206
-
-
Pier, C.L.1
Chen, C.2
Tepp, W.H.3
Lin, G.4
Janda, K.D.5
Barbieri, J.T.6
Pellett, S.7
Johnson, E.A.8
-
16
-
-
33645099746
-
Pharmacology of botulinum toxin: Differences between type A preparations
-
R.L. Rosales, H. Bigalke, and D. Dressler Pharmacology of botulinum toxin: differences between type A preparations Eur. J. Neurol. 13 Suppl. 1 2006 2 10
-
(2006)
Eur. J. Neurol.
, vol.13
, Issue.SUPPL. 1
, pp. 2-10
-
-
Rosales, R.L.1
Bigalke, H.2
Dressler, D.3
-
17
-
-
3242680021
-
Purification and oral toxicities of Clostridium botulinum progenitor toxins
-
G.E. Lewis, Academic Press New York
-
G. Sakaguchi, I. Ohishi, and S. Kozaki Purification and oral toxicities of Clostridium botulinum progenitor toxins G.E. Lewis, Biomedical Aspects of Botulism 1981 Academic Press New York 21 34
-
(1981)
Biomedical Aspects of Botulism
, pp. 21-34
-
-
Sakaguchi, G.1
Ohishi, I.2
Kozaki, S.3
-
18
-
-
0025603668
-
Distinct characters of Clostridium botulinum type A strains and their toxin associated with infant botulism in Japan
-
G. Sakaguchi, S. Sakaguchi, Y. Kamata, K. Tabita, T. Asao, and S. Kozaki Distinct characters of Clostridium botulinum type A strains and their toxin associated with infant botulism in Japan Int. J. Food Microbiol. 11 3-4 1990 231 241
-
(1990)
Int. J. Food Microbiol.
, vol.11
, Issue.34
, pp. 231-241
-
-
Sakaguchi, G.1
Sakaguchi, S.2
Kamata, Y.3
Tabita, K.4
Asao, T.5
Kozaki, S.6
-
19
-
-
68949131091
-
Quantitative determination of the biological activity of botulinum toxin type A by measuring the compound muscle action potential (CMAP) in rats
-
T. Sakamoto, Y. Torii, M. Takahashi, S. Ishida, Y. Goto, H. Nakano, T. Harakawa, A. Ginnaga, S. Kozaki, and R. Kaji Quantitative determination of the biological activity of botulinum toxin type A by measuring the compound muscle action potential (CMAP) in rats Toxicon 54 6 2009 857 861
-
(2009)
Toxicon
, vol.54
, Issue.6
, pp. 857-861
-
-
Sakamoto, T.1
Torii, Y.2
Takahashi, M.3
Ishida, S.4
Goto, Y.5
Nakano, H.6
Harakawa, T.7
Ginnaga, A.8
Kozaki, S.9
Kaji, R.10
-
20
-
-
0030009918
-
Dose-response curve of human extensor digitorum brevis muscle function to intramuscularly injected botulinum toxin type A
-
R.R. Sloop, R.O. Escutin, J.A. Matus, B.A. Cole, and G.W. Peterson Dose-response curve of human extensor digitorum brevis muscle function to intramuscularly injected botulinum toxin type A Neurology 46 5 1996 1382 1386 (Pubitemid 26164651)
-
(1996)
Neurology
, vol.46
, Issue.5
, pp. 1382-1386
-
-
Sloop, R.R.1
Escutin, R.O.2
Matus, J.A.3
Cole, B.A.4
Peterson, G.W.5
-
21
-
-
0016678458
-
Molecular construction of Clostridium botulinum type A toxins
-
S. Sugii, and G. Sakaguchi Molecular construction of Clostridium botulinum type A toxins Infect. Immun. 12 1975 1262 1270
-
(1975)
Infect. Immun.
, vol.12
, pp. 1262-1270
-
-
Sugii, S.1
Sakaguchi, G.2
-
22
-
-
78650679298
-
Comparison of effects of botulinum toxin subtype A1 and A2 using twitch tension assay and rat grip strength test
-
Y. Torii, N. Kiyota, N. Sugimoto, Y. Mori, Y. Goto, T. Harakawa, S. Nakahira, R. Kaji, S. Kozaki, and A. Ginnaga Comparison of effects of botulinum toxin subtype A1 and A2 using twitch tension assay and rat grip strength test Toxicon 57 1 2011 93 99
-
(2011)
Toxicon
, vol.57
, Issue.1
, pp. 93-99
-
-
Torii, Y.1
Kiyota, N.2
Sugimoto, N.3
Mori, Y.4
Goto, Y.5
Harakawa, T.6
Nakahira, S.7
Kaji, R.8
Kozaki, S.9
Ginnaga, A.10
-
23
-
-
34147222256
-
Neurophysiological double-blind trial of a botulinum neurotoxin type A free of complexing proteins
-
DOI 10.1097/01.WNF.0000240951.18821.50, PII 0000282620070300000003
-
K. Wohlfarth, C. Müller, I. Sassin, G. Comes, and S. Grafe Neurophysiological double-blind trial of a botulinum neurotoxin type a free of complexing proteins Clin. Neuropharmacol. 30 2 2007 86 94 (Pubitemid 46581201)
-
(2007)
Clinical Neuropharmacology
, vol.30
, Issue.2
, pp. 86-94
-
-
Wohlfarth, K.1
Muller, C.2
Sassin, I.3
Comes, G.4
Grafe, S.5
-
24
-
-
67349097370
-
®) in volunteers: A double-blind, randomized, dose-ranging study
-
®) in volunteers: a double-blind, randomized, dose-ranging study J. Neurol. 255 12 2008 1932 1939
-
(2008)
J. Neurol.
, vol.255
, Issue.12
, pp. 1932-1939
-
-
Wohlfarth, K.1
Schwandt, I.2
Wegner, F.3
Jürgens, T.4
Gelbrich, G.5
Wagner, A.6
Bogdahn, U.7
Schulte-Mattler, W.8
|